LXRX FY 2008 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$722M

FY 2008 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$32M-35.5% YoY

Gross Profit

$32M100.0% margin

Operating Income

-$97M-298.7% margin

Net Income

-$77M-237.8% margin

EPS (Diluted)

$-3.93

Cash Flow

Operating Cash Flow

-$96M

Free Cash Flow

-$98M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$262M

Total Liabilities

$66M

Stockholders' Equity

$186M

Cash & Equivalents

$86M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$32M	$50M	-35.5%
Gross Profit	$32M	$50M	-35.5%
Operating Income	-$97M	-$75M	-28.8%
Net Income	-$77M	-$59M	-30.7%